Citius Oncology Ratios (2021-2025) | CTOR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Dec2021	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)															79.99%
EBT Margin (Quarter)															-133.61%
EBIT Margin (Quarter)															-133.17%
EBITDA Margin (Quarter)															-133.17%
Operating Margin (Quarter)															-133.17%
Net Margin (Quarter)															-140.31%
FCF Margin (Quarter)															-186.48%
Efficiency
Inventory Average (Quarter)											11.33M	14.86M	16.27M	19.75M	22.46M
Assets Average (Quarter)		0.19M	34.22M	68.50M	69.33M	58.79M	60.18M	60.65M	48.94M	66.78M	87.43M	90.96M	91.57M	96.33M	105.46M
Equity Average (Quarter)		18.13M	18.31M	0.27M	0.10M	12.77M	24.13M	21.29M	18.44M	31.59M	43.71M	38.47M	34.02M	38.63M	51.64M
Invested Capital (Quarter)	0.12M	36.46M	0.35M	0.20M	-0.00M	25.54M	22.73M	19.85M	17.03M	46.14M	41.29M	35.64M	32.40M	44.87M	58.41M
Leverage & Solvency
Interest Coverage Ratio (Quarter)													-30.76	-82.26	-114.58
Debt to Equity (Quarter)	-12.92	0.01
Debt Ratio (Quarter)	1.03	0.75
Equity Ratio (Quarter)	-0.08	141.26	0.01	0.00	0.00	0.53	0.31	0.41	0.35	0.55	0.46	0.39	0.35	0.44	0.53
Times Interest Earned (Quarter)													-30.76	-82.26	-114.58
Valuation
Enterprise Value (Quarter)			-0.29M	-0.12M	-0.37M	-0.03M			-261.00	-112.00	-112.00	-112.00	-112.00	-3.92M	-7.30M
Return Ratios
Return on Sales (Quarter)															-0.01%
Return on Capital Employed (Quarter)							-9.21%	-9.46%	-21.59%		-36.06%	-45.52%	-60.75%	-50.23%	-36.84%
Return on Invested Capital (Quarter)											0.00%	-0.01%	-0.01%	-0.01%	0.00%
Return on Assets (Quarter)				0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)				-0.01%	-0.04%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%